ConductScience.org, home

Paper39786607

Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells.

Hrckulak D and 6 others. Transgenic Res, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells. Papers, record 39786607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39786607

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells.
PubMed
Journal
Transgenic Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-07
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hrckulak DDusan
2Onhajzer JJakub
3Krausova MMichaela
4Stastna MMonika
5Kriz VVitezslav
6Janeckova LLucie
7Korinek VVladimir

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Proto-Oncogene Proteins p21(ras)Major topic
Red Fluorescent ProteinMajor topic
Luminescent ProteinsMajor topic
Animals
Mice
Disease Models, Animal
Lung Neoplasms
DNA Nucleotidyltransferases
Mice, Transgenic
Gene Knock-In Techniques

Source PubMed

Download CSV of topics

Grants13

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
20-31322SGrantová Agentura České RepublikyPubMed
20-31322SGrantová Agentura České RepublikyPubMed
20-31322SGrantová Agentura České RepublikyPubMed
20-31322SGrantová Agentura České RepublikyPubMed
20-31322SGrantová Agentura České RepublikyPubMed
20-31322SGrantová Agentura České RepublikyPubMed
20-31322SGrantová Agentura České RepublikyPubMed
EXCELES, LX22NPO5102Ministerstvo Školství, Mládeže a TělovýchovyPubMed
EXCELES, LX22NPO5102Ministerstvo Školství, Mládeže a TělovýchovyPubMed
EXCELES, LX22NPO5102Ministerstvo Školství, Mládeže a TělovýchovyPubMed
EXCELES, LX22NPO5102Ministerstvo Školství, Mládeže a TělovýchovyPubMed
EXCELES, LX22NPO5102Ministerstvo Školství, Mládeže a TělovýchovyPubMed
EXCELES, LX22NPO5102Ministerstvo Školství, Mládeže a TělovýchovyPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of41030963Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KrasG12D oncogene-expressing tumor cells.https://conductscience.org/library/papers/41030963

Source PubMed

Download CSV of comments and corrections

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116299475A guide to choosing fluorescent proteins.Nat Methods2005https://conductscience.org/library/papers/16299475PubMed
215093544Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.Cancer Cell2004https://conductscience.org/library/papers/15093544PubMed
315121172Utilization of adenovirus vectors for multiple gene transfer applications.Methods2004https://conductscience.org/library/papers/15121172PubMed
421113151Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts.Nature2011https://conductscience.org/library/papers/21113151PubMed
536216931Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor.Nat Med2022https://conductscience.org/library/papers/36216931PubMed
622810696Comprehensive molecular characterization of human colon and rectal cancer.Nature2012https://conductscience.org/library/papers/22810696PubMed
711751630Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.Genes Dev2001https://conductscience.org/library/papers/11751630PubMed
838319359Molecular pathological classification of colorectal cancer-an update.Virchows Arch2024https://conductscience.org/library/papers/38319359PubMed
910835623High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP.Nat Genet2000https://conductscience.org/library/papers/10835623PubMed
1021993244RAS oncogenes: weaving a tumorigenic web.Nat Rev Cancer2011https://conductscience.org/library/papers/21993244PubMed
1126448360Advanced CUBIC protocols for whole-brain and whole-body clearing and imaging.Nat Protoc2015https://conductscience.org/library/papers/26448360PubMed
1225207767Pancreatic adenocarcinoma.N Engl J Med2014https://conductscience.org/library/papers/25207767PubMed
1327163859Cre Recombinase and Other Tyrosine Recombinases.Chem Rev2016https://conductscience.org/library/papers/27163859PubMed
1421376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1525934696HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis.Mol Cancer Res2015https://conductscience.org/library/papers/25934696PubMed
1638105263Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.Signal Transduct Target Ther2023https://conductscience.org/library/papers/38105263PubMed
1714570950Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.JAMA2003https://conductscience.org/library/papers/14570950PubMed
1820023653A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.Nat Neurosci2010https://conductscience.org/library/papers/20023653PubMed
1934919824Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.Lancet Oncol2022https://conductscience.org/library/papers/34919824PubMed
2019329995Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.Nature2009https://conductscience.org/library/papers/19329995PubMed

See all 52 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39786607

GET https://conductscience.org/api/papers/v1/39786607/references?page=2